Trial intelligence / Profile preview

Feasibility of Phrenic Nerve Block in ARF

NCT03978845Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
May 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of lidocaine in acute respiratory failure (ARF), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Reduction of tidal volume or transpulmonary pressure at 20 minutes. Started May 2019; status: completed.

02

Drugs

lidocaine
03

Conditions

acute respiratory failure (ARF)

Beyond the preview

Go deeper on NCT03978845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03978845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call